findmyKOL

Alvin Powers, MD

Basic profile

Tennessee Department of Education

ORCIDNPI
RegionNashville, TN · SoutheastSpecialtyEndocrinology, Diabetes & MetabolismFocusEndocrinology/Metabolic
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publicationSee ScholarshipOnline presenceNot yet checkedPaymentsNone reportedNIH funding1989–2026Why? →

Alvin Powers is an Endocrinology/Metabolic physician affiliated with Tennessee Department of Education. OpenAlex indexes 375 publications with 19,674 citations (h-index 81); ClinicalTrials.gov lists 1 registered study matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Endocrinology, Diabetes & Metabolism profiles in the findmyKOL directory.

Overview

Scholarship

indexed output and impact (OpenAlex)
375publications

Distinct works indexed by OpenAlex, matched via ORCID.

19,674citations

Total citations across indexed works.

81h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1clinical trials

Investigator role on registered studies.

View trials
32NIH grants · 1989–2026

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

3601 The Vanderbilt Clinic
Nashville, TN 372320001

Telephone

615-322-3000

Provider last certified this registry record 30 Mar 2022.

View the NPPES registry record

Clinical trials

Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    55.8%
    Insulin Analog30.8%
    Lantus Solostar100%
    Part D<11 patients
    GLP-1 receptor agonist25%
    Ozempic100%
    Part D<11 patients
  • Hormonal (systemic)

    44.2%
    l-Thyroxine44.2%
    Levothyroxine Sodium100%
    Part D<11 patients
Where care is delivered (Part B), 2022100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

32 NIH research awards on record, funded 19892026 per NIH RePORTER. The latest:

201 more award records behind the reveal.Reveal →

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”